Patients are encouraged to adopt a balanced diet and engage in regular physical activity
While this medication produces substantial weight lossaveraging 15-22% of initial body weight in clinical trialspatients and providers often question whether tirzepatide causes muscle loss alongside fat reduction
The incidence of gastroparesis, a disorder that delays or stops food movement within the GI tract, is unsurprising considering that GLP-1 RAs induce weight loss by slowing gastric emptying
In AP, the abnormal activation of lipase and the excessive accumulation of fatty acids are significant factors that exacerbate disease severity
They work differently, and they fit different people and goals
Kathryn Kline, MD, Texas Medical Board License T3117 Standard Texas Telehealth Medical Disclaimer Medical Disclaimer: The information provided in this article is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment